Silence Therapeutics (SLN) Retained Earnings (2018 - 2026)
Silence Therapeutics (SLN) reported Retained Earnings of -$3.4 million for Q1 2026, up 99.33% on a YoY basis from -$1.7 million in Q1 2025, and up 99.4% sequentially from -$562.6 million in Q4 2025.
Silence Therapeutics (SLN) Retained Earnings (2018 - 2026) Analysis & Trends
Silence Therapeutics (SLN) has 9 years of Retained Earnings data on file, last reported at -$3.4 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 99.33% year-over-year to -$3.4 million; the trailing twelve-month figure through Mar 2026 stood at -$3.4 million (up 99.33% YoY), and the FY2025 full-year result was -$562.6 million, down 4675.25% from the prior year.
- Retained Earnings improved to -$3.4 million in Q1 2026, from -$562.6 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$3.4 million in Q1 2026 to a low of -$562.6 million in Q4 2025.
- A 5-year average of -$356.0 million and a median of -$440.3 million in 2023 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings plunged 4675.25% in 2025 and jumped 99.33% in 2026, its largest moves.
- Tracing SLN's Retained Earnings over 5 years: stood at -$308.8 million in 2022, then decreased by 22.43% to -$378.1 million in 2023, then jumped by 96.88% to -$11.8 million in 2024, then sank by 4675.25% to -$562.6 million in 2025, then jumped by 99.4% to -$3.4 million in 2026.
- Business Quant data shows SLN's Retained Earnings at -$3.4 million in Q1 2026, -$562.6 million in Q4 2025, and -$550.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Silence Therapeutics | 1.62 Bn | 1.49 Bn | 411,000.00 | -3.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.37 Mn |
| Dec 31, 2025 | -562.57 Mn |
| Sep 30, 2025 | -550.80 Mn |
| Jun 30, 2025 | -529.80 Mn |
| Mar 31, 2025 | -502.50 Mn |
| Dec 31, 2024 | -11.78 Mn |
| Dec 31, 2023 | -378.05 Mn |
| Dec 31, 2022 | -308.79 Mn |
| Dec 31, 2021 | -300.56 Mn |
| Dec 31, 2020 | -243.25 Mn |
| Dec 31, 2019 | -195.43 Mn |
| Dec 31, 2018 | -172.14 Mn |